Get started
ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT)ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT)ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT)

ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

0HHJ chart


Full chart

0HHJ upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪804.43 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.855 USD
Net income (FY)
‪−6.98 M‬ USD
Revenue (FY)
‪75.72 K‬ USD
Shares float
‪2.94 M‬
Beta (1Y)
2.42

Employees


Employees (FY)
8
Change (1Y)
0
Revenue / Employee (1Y)
‪9.47 K‬ USD
Net income / Employee (1Y)
‪−872.85 K‬ USD

About Arch Therapeutics, Inc.


Sector
Distribution Services
Industry
Medical Distributors
CEO
Terrence W. Norchi
Website
archtherapeutics.com
Headquarters
Framingham
Founded
2009
FIGI
BBG00JWMZ817
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0HHJ news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0HHJ is 0.180 USD — it has decreased by −77.38% in the past 24 hours. Watch ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) stocks are traded under the ticker 0HHJ.
0HHJ stock has fallen by −77.38% compared to the previous week, the month change is a −77.38% fall, over the last year ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) has showed a −77.38% decrease.
0HHJ reached its all-time high on May 22, 2018 with the price of 86.800 USD, and its all-time low was 0.180 USD and was reached on Jan 24, 2025. View more price dynamics on 0HHJ chart.
See other stocks reaching their highest and lowest prices.
0HHJ stock is 341.99% volatile and has beta coefficient of 2.42. Track ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) there?
Today ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) has the market capitalization of ‪804.43 K‬, it has increased by 5.05% over the last week.
Yes, you can track ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
0HHJ net income for the last quarter is ‪−5.65 M‬ USD, while the quarter before that showed ‪−1.47 M‬ USD of net income which accounts for −284.90% change. Track more ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) financial stats to get the full picture.
No, 0HHJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 26, 2025, the company has 8.00 employees. See our rating of the largest employees — is ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) EBITDA is ‪−4.72 M‬ USD, and current EBITDA margin is ‪−6.66 K‬%. See more stats in ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) financial statements.
Like other stocks, 0HHJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) stock shows the neutral signal. See more of ARCH THERAPEUTICS INC COM USD0.001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.